Platinum-resistant Ovarian Cancer Active Not Recruiting Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Platinum drug resistant Ovarian cancer / Platinum-resistant Ovarian Cancer (PROC) / Platinum Resistant Ovarian Cancer

IndicationStatusPhase
DBCOND0068919 (Platinum-resistant Ovarian Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04374630Study With Afuresertib and Paclitaxel in Platinum Resistant OvarianTreatment